Latest 12 months Revenue for Imarx Therapeutics is Down -70.64% according to T12-NEWS
Stock Quote:(N/A:IMRX)
08/24/2009
0.00
N/A
N/A
Latest 12 months Revenue for Imarx Therapeutics is Down -70.64% according to T12-NEWS
Last
Price Change
% Chg
Volume
New York, NY, August 24, 2009,T12-NEWS reports that Revenue for Imarx Therapeutics (OTC:IMRX) for its twelve months ended June 30, 2009 was $2,669,000, a -70.64% decrease over the year earlier same tw ... read full story
U.S. markets ended higher despite the lack of an agreement again today in Greece. A meeting of coalition party leaders in Athens was postponed until tomorrow. Greek Prime Minister Lucas Papademos and the political leaders met again today to try to ag ... read full story
N/A 
